Adipocytokine levels mark endothelial function in normotensive individuals

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Solini, Anna ^a   Stea, Francesco ^a   Santini, Eleonora ^a   Bruno, Rosa M ^a   Duranti, Emiliano ^a   Taddei, Stefano ^a   Ghiadoni, Lorenzo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Adipocytokine; Endothelium; Resistin; Retinol binding protein 4

Indexed keywords

ADIPOCYTOKINE; GLYCERYL TRINITRATE; MALONALDEHYDE; RESISTIN; RETINOL BINDING PROTEIN 4;

ADULT; ARTICLE; AUTOMATION; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; BRACHIAL ARTERY; CELL FUNCTION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; FEMALE; FLOW MEDIATED DILATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RADIOIMMUNOASSAY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SERUM; VASCULAR ENDOTHELIUM; VASODILATATION; WAIST CIRCUMFERENCE;

ADIPOKINES; ADIPOSE TISSUE; ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NITROGLYCERIN; OXIDATIVE STRESS; RADIOIMMUNOASSAY; RESISTIN; RETINOL-BINDING PROTEINS, PLASMA; VASODILATION; VASODILATOR AGENTS; WAIST CIRCUMFERENCE;

EID: 84865535769     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-103     Document Type: Article

References (43)

1. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115:1285-1295.
2. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005, 111:363-368. 10.1161/01.CIR.0000153339.27064.14, 15668353.
3. Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Inflammation in peripheral artery disease. Circulation 2010, 122:1862-1875. 10.1161/CIRCULATIONAHA.109.918417, 21041698.
4. Wong WT, Wong SL, Tian XY, Huang Y. Endothelial dysfunction: the common consequence in diabetes and hypertension. J Cardiovasc Pharmacol 2010, 55:300-307. 10.1097/FJC.0b013e3181d7671c, 20422734.
5. Yan G, You B, Chen SP, Liao JK, Sun J. Tumor necrosis factor-alpha downregulates endothelial nitric oxide synthase mRNA stability via translation elongation factor 1-alpha 1. Circ Res 2008, 103:591-597. 10.1161/CIRCRESAHA.108.173963, 2753820, 18688046.
6. Watanabe S, Mu W, Kahn A, Jing N, Li JH, Lan HY, et al. Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells. Am J Nephrol 2004, 24:387-392. 10.1159/000079706, 15256805.
7. Mody N, Graham TE, Tsuji Y, Yang Q, Kahn BB. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am J Physiol Endocrinol Metab 2008, 294:E785-E793. 10.1152/ajpendo.00521.2007, 2711779, 18285525.
8. Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006, 354:2552-2563. 10.1056/NEJMoa054862, 16775236.
9. Hu C, Jia W, Zhang R, Wang C, Lu J, Wu H, et al. Effect of RBP4 gene variants on circulating RBP4 concentration and type 2 diabetes in a Chinese population. Diabet Med 2008, 25:11-18. 10.1111/j.1464-5491.2007.02314.x, 18199128.
10. Park SE, Kim DH, Lee JH, Park JS, Kang ES, Ahn CW, et al. Retinol-binding protein-4 is associated with endothelial dysfunction in adults with newly diagnosed type 2 diabetes mellitus. Atherosclerosis 2009, 204:23-25. 10.1016/j.atherosclerosis.2008.08.012, 18838136.
11. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007, 92:2712-2719. 10.1210/jc.2006-1249, 17440021.
12. Solini A, Santini E, Madec S, Rossi C, Muscelli E. Retinol-binding protein-4 in women with untreated essential hypertension. Am J Hypertens 2009, 22:1001-1006. 10.1038/ajh.2009.116, 19556974.
13. Lim S, Yoon JW, Choi SH, Park YJ, Lee JJ, Park JH, et al. Combined impact of adiponectin and retinol-binding protein 4 on metabolic syndrome in elderly people: the Korean Longitudinal Study on Health and Aging. Obesity (Silver Spring) 2010, 18:826-832.
14. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111:932-939. 10.1161/01.CIR.0000155620.10387.43, 15710760.
15. Hsu WY, Chao YW, Tsai YL, Lien CC, Chang CF, Deng MC, et al. Resistin induces monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1 expression in endothelial cells via p38MAPK-dependent pathway. J Cell Physiol 2011, 226:2181-2188. 10.1002/jcp.22555, 21520070.
16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germanò G, et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187. 10.1097/HJH.0b013e3281fc975a, 17563527.
17. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of the European Society of Hypertension. J Hypertens 2005, 23:7-17. 10.1097/00004872-200501000-00004, 15643116.
18. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003, 41:1281-1286. 10.1161/01.HYP.0000070956.57418.22, 12719441.
19. Gemignani V, Faita F, Ghiadoni L, Poggianti E, Demi M. A system for real-time measurement of the brachial artery diameter in B-mode ultrasound images. IEEE Trans Med Imaging 2007, 26:393-404.
20. Gemignani V, Bianchini E, Faita F, Giannarelli C, Plantinga Y, Ghiadoni L, et al. Ultrasound measurement of the brachial artery flow-mediated dilation without ECG gating. Ultrasound Med Biol 2008, 34:385-391. 10.1016/j.ultrasmedbio.2007.08.006, 17964069.
21. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612. 2763564, 19414839.
22. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990, 186:407-421.
23. Bobbert T, Raila Schwarz JF, Mai K, Henze A, Pfeiffer AF, et al. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis 2010, 213:549-551. 10.1016/j.atherosclerosis.2010.07.063, 20832065.
24. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003, 108:736-740. 10.1161/01.CIR.0000084503.91330.49, 12874180.
25. Papadopoulos DP, Makris TK, Krespi PG, Poulakou M, Stavroulakis G, Hatzizacharias AN, et al. Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens (Greenwich) 2005, 7:729-733.
26. Kotani K, Adachi S, Tsuzaki K, Sakane N, Gugliucci A. The association between resistin, high-density lipoprotein cholesterol and carotid atherosclerosis in elderly women with hypertension. Int J Cardiol 2010, 14:193-194.
27. Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, et al. Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans. Nutr Metab (Lond) 2012, 9:68. [Epub ahead of print] PMID:22828276.
28. Gao S, Wang YH, Li M. Cigarette smoking increases levels of retinol-binding protein-4 in healthy men with normal glucose tolerance. Chin Med J (Engl) 2012, 125:1686-1689.
29. Choi HY, Kim S, Yang SJ, Yoo HJ, Seo JA, Kim SG, et al. Association of adiponectin, resistin, and vascular inflammation: analysis with 18F-fluorodeoxyglucose positron emission tomography. Arterioscler Thromb Vasc Biol 2011, 31:944-949. 10.1161/ATVBAHA.110.220673, 21212400.
30. Zhang MH, Na B, Schiller NB, Whooley MA. Resistin, exercise capacity, and inducible ischemia in patients with stable coronary heart disease: data from the Heart and Soul study. Atherosclerosis 2010, 213:604-610. 10.1016/j.atherosclerosis.2010.09.015, 20951381.
31. Lee SH, Ha JW, Kim JS, Choi EY, Park S, Kang SM, et al. Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry. Coron Artery Dis 2009, 20:33-39. 10.1097/MCA.0b013e328318ecb0, 18997620.
32. Kawamura R, Doi Y, Osawa H, Ninomiya T, Hata J, Yonemoto K, et al. Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study. Nephrol Dial Transplant 2010, 25:3236-3240. 10.1093/ndt/gfq155, 20339098.
33. De Caterina R, Ghiadoni L, Taddei S, Virdis A, Almerigogna F, Basta G, et al. Soluble E-selectin in essential hypertension: a correlate of vascular structural changes. Am J Hypertens 2001, 14:259-266. 10.1016/S0895-7061(00)01276-0, 11281238.
34. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 2009, 32:S314-S321. 10.2337/dc09-S330, 2811443, 19875572.
35. Huang G, Wang D, Khan UI, Zeb I, Manson JE, Miller V, et al. Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study. Cardiovasc Diabetol 2012, 11:52. [Epub ahead of print] PMID: 22587616, 10.1186/1475-2840-11-52, 3461442, 22587616.
36. Jung CH, Kim BY, Kim CH, Kang SK, Jung SH, Mok JO. Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients. Cardiovasc Diabetol 2012, 11:24. 10.1186/1475-2840-11-24, 3353195, 22413919.
37. Kougias P, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries. J Vasc Surg 2005, 41:691-698. 10.1016/j.jvs.2004.12.046, 15874935.
38. Chen C, Jiang J, Lü JM, Chai H, Wang X, Lin PH, et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 2010, 299:H193-H201. 10.1152/ajpheart.00431.2009, 2904138, 20435848.
39. Barac A, Campia U, Matuskey LA, Lu L, Panza JA. Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension. Am J Cardiol 2008, 101:980-985. 10.1016/j.amjcard.2007.11.058, 18359318.
40. Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Koh Y, et al. Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs. Int J Cardiol 2010, 140:73-81. 10.1016/j.ijcard.2008.11.017, 2862263, 19059660.
41. Rossi R, Chiurlia E, Nuzzo A, Cioni E, Origliani G, Modena MG. Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J Am Coll Cardiol 2004, 44:1636-1640. 10.1016/j.jacc.2004.07.027, 15489096.
42. Zhang L, Curhan GC, Forman JP. Plasma resistin levels associate with risk for hypertension among nondiabetic women. J Am Soc Nephrol 2010, 21:1185-1191. 10.1681/ASN.2009101053, 3152237, 20378819.
43. Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J, et al. Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond) 2009, 116:219-230.